Unauthorized Botox may pose serious health risks
Posted on September 30, 2019 For immediate release 
Month: September 2019
Pediatricians Stand By Meds For ADHD, But Some Say Therapy Should Come First
Posted onThe American Academy of Pediatrics is out with new guidelines on ADHD that some hoped would boost the role of behavioral interventions before medications. But the AAP stuck by its recommendation that children 6 and older should be given medicine combined with therapy after diagnosis.
The Delicate Issue Of Taking Away A Senior’s Smartphone
Posted onKnowing when — and how — to limit a loved one’s access to digital devices is akin to taking their car keys.
Want To Reduce Suicides? Follow The Data — To Medical Offices, Motels And Even Animal Shelters
Posted onAn Oregon epidemiologist is using data to find patterns in suicides, then offering prevention training at the motels where people keep taking their lives, the animal shelter where they give away their pets, the pain clinics where patients struggle. Her model is spreading to New York, California and elsewhere.
RW Consumer Products Ltd. voluntarily recalls all lots of “Gripe Water – Alcohol And Preservative Free” because of microbial contamination
Posted on OTTAWA – Health Canada is advising Canadians that RW Consumer Products Ltd. is recalling all lots of the product “Gripe Water – Alcohol And Preservative Free” (Natural Product Number [NPN] 80080669), sold under various brand names, because company testing showed microbial contamination. These products have been sold at retailers across Canada. 
Health Canada requests that companies stop distributing ranitidine drugs in Canada while it assesses NDMA; some products being recalled
Posted onOTTAWA – Health Canada recently informed Canadians that it is assessing the issue of an impurity called N-nitrosodimethylamine (NDMA) detected in some ranitidine drugs. Current evidence suggests that NDMA may be present in ranitidine, regardless of the manufacturer. As a result, and at Health Canada’s request, companies marketing ranitidine products in Canada have stopped any further distribution until evidence is provided to demonstrate that they do not contain NDMA above acceptable levels.
Health Canada advises Canadians to exercise caution when taking gabapentin or pregabalin with opioids
Posted onSeptember 17, 2019 For Immediate Release
Health Canada assessing NDMA in ranitidine
Posted onFor Immediate Release
Needle-free dermal filler devices used for cosmetic skin treatments are not authorized in Canada and may pose health risks
Posted onOTTAWA – Health Canada is advising Canadians that needle-free dermal filler devices that are promoted for cosmetic skin treatments—such as reducing wrinkles and increasing lip volume—may pose health risks. These small handheld medical devices used to deposit hyaluronic acid or other dermal fillers under the skin are also known as hyaluron pens, hyapens, fog injection devices, SERA pens, and nebulizer injector guns.
‘Crackhouse’ Or ‘Safehouse’? U.S. Officials Try To Block Philly’s Supervised Injection Site
Posted onAn average of three people a day died of opioid overdose in Philadelphia in 2018. But efforts to combat the crisis with a supervised injection site could be stymied by “the crackhouse statute,” a portion of federal law meant to protect neighborhoods during the crack epidemic of the 1980s.